Inhibrx Biosciences, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Regulation FD Disclosure

Notice of Effectiveness

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Certification of approval for listing and registration on a national securities exchange

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Lappe Mark

Kayyem Jon Faiz

MANHARD KIMBERLY

Vuori Kristiina MD

FORSYTH DOUGLAS

Kayyem Jon Faiz

Kayyem Jon Faiz

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

MANHARD KIMBERLY

FORSYTH DOUGLAS

Lappe Mark

MANHARD KIMBERLY

Kayyem Jon Faiz

PERCEPTIVE ADVISORS LLC

VIKING GLOBAL INVESTORS LP

Schonfeld Strategic Advisors LLC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Post-effective amendment filed solely to add exhibits

Letter from the SEC

Correspondence with the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)